Incyte Reports 2017 First-Quarter Financial Results and Updates on Key Clinical Programs

Go back to Incyte Reports 2017 First-Quarter Financial Results and Updates on Key Clinical Programs
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 124.69 +0.29 (0.23%)
Previous Close $124.40    52 Week High $118.49 
Open $125.66    52 Week Low $55.00 
Day High $126.06    P/E N/A 
Day Low $123.57    EPS $-0.56 
Volume 72,117